Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

PACB - Pacific Biosciences of California,... | Finranks

Home

PACB

P

Pacific Biosciences of California, Inc. (PACB)

NMS – Real vaqt narxi. Valyuta: USD

1.26

-0.09 (-6.67%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

1.27

+0.01 (0.79%)

Bozordan keyin: Mar 27, 2026, 7:45 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note

Pacific Biosciences of California (PACB) Registers a Bigger Fall Than the Market: Important Facts to Note

The latest trading day saw Pacific Biosciences of California (PACB) settling at $1.26, representing a -6.67% change from its previous close.

PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative

PacBio Wins Basecamp Research Deal for Trillion Gene Atlas Initiative

PACB wins Basecamp deal to power Trillion Gene Atlas using HiFi sequencing, advancing AI-driven drug discovery with high-accuracy genomic data.

Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?

Pacific Biosciences (PACB) Upgraded to Strong Buy: What Does It Mean for the Stock?

Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

PacBio's Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics PacBio's Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub

PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub

PACB teams with DNAstack to launch a global HiFi genome network, linking 10,000+ sequences to boost rare disease research without moving data.

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

Collaboration powers secure international data sharing through the HiFi Solves Global Consortium Collaboration powers secure international data sharing through the HiFi Solves Global Consortium

Videolar

No Data

There is no data to display

Press-relizlar

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative

PacBio's Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics PacBio's Revio system and SPRQ-Nx chemistry to enable an order-of-magnitude expansion of HiFi metagenomic sequencing for scaling AI-designed therapeutics

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

PacBio Announces the Appointment of Chris Gibson to the Board of Directors

Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing Proven experience in leveraging AI in biology will strengthen the board of directors as PacBio develops data tools to maximize the power of HiFi sequencing

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research

Collaboration powers secure international data sharing through the HiFi Solves Global Consortium Collaboration powers secure international data sharing through the HiFi Solves Global Consortium

PacBio to Participate in the TD Cowen 46th Annual Health Care Conference

PacBio to Participate in the TD Cowen 46th Annual Health Care Conference

MENLO PARK, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026, at 2:30 PM ET in Boston, MA.